Effects of exogenous porcine growth hormone administration between 30 and 60 kilograms on the subsequent and overall performance of pigs grown to 90 kilograms

Muscle type-specific responses of myoD and calpain 3 expression to recombinant porcine growth hormone in the pig

Sixteen castrated male Large White × Landrace pigs were employed to investigate the muscle type-specific changes of gene expression in response to recombinant porcine growth hormone (rpGH) administration. Pigs were injected intramuscularly with rpGH (4 mg/day, n = 8) or saline (n = 8) for 28 days. Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to determine the mRNA abundance of genes related to muscle growth in longissimus dorsi (LD) and semitendinosus (ST) muscles. Myofibre-type composition was characterised by the ratio of the expression of myosin heavy chain (MyHC) 1, 2a or 2b relative to 2x. The results showed that the relative myofibre-type composition of neither LD nor ST was affected by rpGH administration. rpGH administration did not induce significant changes in the abundances of myostatin and myogenin mRNA in both types of muscle. MyoD and calpain 3 mRNA were significantly increased after rpGH treatment in ST muscle, whereas the difference was not significant in LD muscle. A tendency of down-regulation was observed for PGC-1α mRNA expression in ST muscle of rpGH-treated group (P = 0.16). These results suggest that myoD, calpain 3 and probably PGC-1α may be involved in the mechanism of exogenous GH action on skeletal muscle growth; rpGH up-regulates mRNA expression of myoD and calpain 3 in a muscle type-specific manner, being more remarkable in ST than in LD, whereas no influences of rpGH on the mRNA expression of myostatin and myogenin were detected.

A review of the factors influencing the development of intermuscular adipose tissue in the growing pig

Compared with subcutaneous or abdominal fat depots of pig carcasses, intermuscular fat displays a number of original properties. It cannot be easily removed from fresh or processed meat delivered to consumers and has therefore an influence on consumer acceptability of pork. Particular compositional characteristics of intermuscular fat include low lipid content and small size of adipocytes. How age (or body weight), gender, castration, environmental temperature, feeding restriction, diet composition, as well as genetic factors affect intermuscular fat development and composition are surveyed in this review paper. Up to now, few studies have specifically dealt with the intermuscular compartment of body fat while very abundant information is available on the subcutaneous one. As a general rule, any factor, either genetic or non-genetic, which causes a decrease of whole carcass fat deposition generates a higher relative importance of the intermuscular fraction of total fat as well as an increased degree of unsaturation of constituent fatty acids.

Myogenesis and muscle metabolism in juvenile Atlantic salmon (Salmo salar) made transgenic for growth hormone

Atlantic salmon (Salmo salar) made transgenic for growth hormone(GH) and non-transgenic salmon were sampled at 4 and 7 months of age to estimate myogenic factors, satellite cell proliferation and metabolic enzyme activities. The growth rate of 4 month old transgenic salmon was higher than that of non-transgenic salmon. Myosatellite cell (MC) proliferation rates were higher in cells isolated from GH-transgenic salmon compared with cells from non-transgenic salmon of the same mass. Moreover, MCs extracted from non-transgenic salmon demonstrated a higher proliferation capacity when exposed in vitro to salmon GH. White muscle MyoD I mRNA content was higher in transgenic and non-transgenic salmon at 7 months compared with that at 4 months, indicating an effect of age on MyoD I mRNA expression. White muscle myogenin mRNA content varied with fish age and presence of the transgene, and was higher in transgenic fish at 7 months, suggesting a higher differentiation capacity. MyoD I, MyoD II and myogenin mRNA content was higher in red muscle of GH-transgenic fish at 7 months compared with non-transgenic salmon at 7 months. However, red muscle myogenic factor expression was not different between transgenic and non-transgenic fish of the same weight. Enzyme activities in white muscle and liver were highly affected by the presence of the transgene, although this effect was generally dependent on the age of the fish. Glycolytic and oxidative enzyme activities were increased in transgenic salmon liver, indicating a higher metabolic rate in transgenics. This study demonstrates that (1) the higher growth rate of transgenic salmon particularly at 4 months of age could be explained at least in part by higher numbers and proliferation rates of MCs, (2) GH can directly stimulate the proliferation of myosatellite cells extracted from salmon, indicating that GH is one possible factor involved in the higher myosatellite cell proliferation rates in transgenic salmon, (3) MyoD and myogenin mRNA expression are affected by fish age, and (4) metabolic enzyme activities are affected by the age of the fish at least in liver and white muscle, and any transgene effect is dependent upon the age of the fish.

Exogenous porcine somatotropin administered to neonatal pigs at high doses can alter lifetime fat but not lean tissue deposition

The growth rate of the young pig is generally much less than its potential and may be constrained by endocrine status as well as nutrient intake. The aim of the present study was to determine whether porcine (p) somatotropin (ST) treatment of the sucking pig could alter subsequent body composition. Twelve mixed-parity cross-bred sows with an average litter size of ten piglets were used to nurse pigs for the present study. On day 1 of lactation, the median two male pigs (by weight) from each litter were randomly allocated to one of two doses of pST (0 or 1 mg/kg per d) until weaning on day 21. Pigs were weaned and offered feed ad libitum until slaughter at 134 d of age. Body composition was measured using dual-energy X-ray absorptiometry (DXA) at 21, 49, 77, 105 and 133 d of age. There was no significant difference in growth rates between day 1 and 21 of lactation in pigs injected with either saline (9 g/l NaCl/l) or pST (258 v. 246 g/d for control and pST-treated pigs respectively, P=0.61), and as a consequence there was no significant difference in liveweight at weaning (7.13 v. 6.84 kg, P=0.59). However, fat mass at weaning tended to be decreased (1.18 v. 0.96 kg, P=0.064), while the % fat in the body at weaning was significantly (16.7 v. 13.9 %, P=0.008) decreased by exogenous pST treatment. In the immediate post-weaning period there was a reduction in lean tissue deposition (347 v. 300 g/d, P=0.021) but no effect on fat deposition (35 v. 33 g/d, P=0.72). Over the entire weaning-to-slaughter period, pST treatment of neonatal pigs decreased the rate of fat deposition (130 v. 112 g/d, P=0.033), but had no effect on lean tissue deposition (550 v. 538 g/d, P=0.49). Therefore, treatment of nursing pigs with high doses of pST for a short period before weaning may provide a means of reducing the fat content of pork and pork products.

Manipulation of growth in pigs through treatment of the neonate with clenbuterol and somatotropin

Neonatal pigs were treated with lipolytic agents to determine whether this would cause a long-term decrease in their ability to deposit fat, with a consequent increase in muscle growth and feed efficiency. Groups of 25 female piglets were given clenbuterol (100 microg/kg BW), porcine somatotropin (pST; 100 microg/kg BW), pST plus clenbuterol, or saline injections from 3 d to 40 d of age. Five piglets from each group were then slaughtered to determine body composition. Clenbuterol and pST both increased ADG up to weaning when given separately (24%, P < 0.05; 20%, P < 0.1 respectively) but did not reduce fat deposition. In contrast, pigs given clenbuterol plus pST showed no increase in ADG and a 41% reduction in carcass fat (P < 0.05). Clenbuterol caused a marked decrease in beta2-adrenoceptor density in porcine adipose tissue (P < 0.001) and skeletal muscle (P < 0.01). This effect was attenuated by concurrent pST treatment, which helps to explain the synergistic effect of these drugs on fat deposition. Once the drugs were withdrawn at 40 d, the anabolic effect of pST gradually disappeared, so that the live weight of pST-treated and control pigs was identical at 168 d. Clenbuterol withdrawal caused the rapid loss of extra weight gained, plus an additional 4 to 5 kg live weight that was never recovered. During the 4-wk finishing period there was an increase in feed intake in pigs that had previously undergone treatment with pST (23%, P < 0.1), with no increase in ADG, and so feed efficiency was impaired (P < 0.05). Pigs that were treated with pST plus clenbuterol showed no marked increase in feed intake during this period. Carcasses from clenbuterol-treated pigs tended to be leaner at 168 d, but there was no long-term effect of pST or the combined treatment on carcass composition. Overall, the treatment of neonatal pigs with repartitioning agents was counter-productive, due to the withdrawal effects of the beta-adrenefgic agonist and the delayed long-term effect of pST on feed intake.

The effect of GH and IGF-I on preadipocytes from Large White and Meishan pigs in primary culture

Proliferation and differentiation of preadipocytes from 7-day-old Large White (LW) and Meishan (MS) pigs were studied in primary culture. The effects of porcine GH (pGH) and IGF-I as well as the expression of GH (GHR) and IGF-I (IGF-IR) receptors mRNA were examined. Preadipocytes were exposed to serum-supplemented and serum-free medium to determine proliferation and differentiation, respectively. Proliferation was higher in MS than in LW pigs. Treatment with pGH (2 nM) or IGF-I (10 nM) resulted in a similar decrease in proliferation in LW and MS pigs. Parameters assessing differentiation and the effects of pGH and IGF-I on differentiation did not differ between the two breeds. The percentage of differentiating cells and LPL and ME activities were markedly reduced by pGH. IGF-I did not reduce differentiation significantly. Both GHR and IGF-IR mRNA were expressed in adipose tissue, adipocytes, preadipocytes, and 6-day-cultured cells from LW and MS pigs. The similar action of pGH and IGF-I on preadipocyte proliferation and differentiation, associated with the similar expression of GHR and IGF-IR mRNA in LW and MS pigs, suggests that the GH/IGF-I axis is not impaired in MS pigs. The difference in preadipocyte proliferation observed between LW and MS pigs could account for their adiposity difference.

Natural sex steroids and their xenobiotic analogs in animal production: growth, carcass quality, pharmacokinetics, metabolism, mode of action, residues, methods, and epidemiology

Natural and xenobiotic compounds having sex-related actions have long been used for growth promotion and various changes in carcass quality in meat animals. The first compounds used were synthetic estrogens; however, later on a whole battery of compounds having androgenic, and progestogenic actions have also been involved. In surveying the effects of these compounds in meat-producing animals, it became clear that these drugs increase the growth rate of the treated animals and bring about changes in the carcass that are generally characterized by lower fat content and more lean mass. Extensive studies undertaken in various countries, including the European Economic Community (EEC), have shown that if used according to good husbandry practices, the meat from treated animals does not have excessive amounts of residues compared with the endogenous amount of steroid production in the animals in question and also in human beings. The banning of these compounds in the European community brought a new phenomenon of illegal or black market cocktails. These mixtures of anabolic steroids are injected into the body of the animals rather than implanted in the ears, which is the normal practice in countries where they have not yet been banned. Several screening and confirmatory methods are now available for monitoring programs. However, these programs need excessive resources in terms of manpower, funds, and proper legislation, which in underdeveloped countries is questionable, particularly in the absence of strong scientific evidence for the exercise.

Development of obesity following inactivation of a growth hormone transgene in mice

Mice with a temporally regulatable ovine metallothionein 1a--ovine growth hormone transgene (oMT1a-oGH) were utilized to study the effects of withdrawal of elevated circulating levels of growth hormone (GH) on growth and body composition. The transgene was activated from 21-42 days of age by provision of zinc sulfate in the drinking water. At 42 days, mice were allocated to either activated transgenic (remain on zinc sulfate) or inactivated transgenic (removal of zinc sulfate) groups, and to receive either ad libitum or restricted (80-90% of ad libitum) access to feed. Non-transgenic control mice were treated similarly. Body weights and intakes were recorded weekly. Mice were killed at 70 d and epididymal and subcutaneous fat pads, trimmed hind carcass and various organs were weighed. The main findings of this study are: (1) food-restricted mice possessing an activated oMT1a-oGH transgene fail to demonstrate increased growth, but exhibit significantly reduced levels of fat (P < 0.05) relative to all other genotype x feed level combinations; and (2) inactivation of the oMT1a-oGH transgene, following a period of elevated GH levels, leads to development of obesity as evidenced by two to three fold increases in epididymal and subcutaneous fat pad weights (P < 0.01) relative to both activated transgenic and non-transgenic control mice. These large increases in fat deposition also occurred when intake was restricted to 80-90% of ad libitum levels, indicating that metabolic changes independent of intake occur in these inactivated transgenic mice. It is possible that highly elevated production of GH in activated oMT1a-oGH transgenic mice leads to (1) enhanced promotion of preadipocyte differentiation, leading to increased numbers of adipocytes that, upon cessation of oGH production, are available for lipid deposition resulting in obesity, or (2) alterations in production of or responsiveness to insulin, leading to increased fat deposition upon removal of the chronic anti-lipogenic actions of GH. The oMT1a-oGH transgenic mouse line should provide a new genetic model with which to investigate the mechanisms by which growth hormone affects obesity.

Effect of dietary energy intake and exogenous porcine growth hormone administration on circulating porcine growth hormone concentration and response to human growth hormone-releasing factor administration in growing swine

In a 2 x 2 treatment array (n = 4 pigs/treatment), the effects of feed intake (ad libitum vs. restricted to 60% ad libitum) and the daily administration of excipient buffer or porcine pituitary-derived growth hormone (GH) at a dose of 100 micrograms/kg body weight per day on serum GH profile and human growth hormone-releasing factor (hGRF) response were examined in barrows weighing 55 kg. Feed intake treatment was implemented from 25 to 55 kg live weight. Buffer or GH treatment was implemented for 10 d before sampling. After GH treatment, the integrated serum GH concentration area was 25% greater in barrows fed restrictively. Data are consistent with the suggestion that GH dose to improve the efficiency of lean tissue deposition be adjusted according to feeding regimen. The serum GH response to hGRF was also altered by level of feed intake. The ad libitum feeding of buffer-treated animals resulted in a monophasic serum GH response to hGRF, whereas barrows fed restrictively had a biphasic response to hGRF. Together, these data suggest that feed intake pattern alters GH secretion and as such could influence the practical implementation of somatotropin as a metabolism modifier in swine.

Recombinant bovine and porcine somatotropin: safety and benefits of these biotechnologies

This article reviews the literature about the safety and benefits of two recombinantly derived proteins, bovine somatotropin (bST) and porcine somatotropin (pST), that likely will be used in animal agriculture in the future. When administered to dairy cows, bST increases milk production per cow approximately 15% to 20% and improves productive efficiency approximately 10%. Administration of pST to growing pigs reduces carcass fat content by as much as 70% to 80% and improves productive efficiency 15% to 35%. Because meat is a major source of total fat and saturated fatty acids in the diets of human beings, pST will allow consumers to include leaner, more nutrient-dense pork in their diets and still meet current dietary guidelines. Although these biotechnologies have not yet received regulatory approval from the Food and Drug Administration (FDA) for commercial use, information published by the FDA, the National Institutes of Health, the US Congress Office of Technology Assessment, and the American Academy of Pediatrics, as well as an extensive body of scientific evidence, indicate that these products are safe for the consumer. Nonetheless, it is important that consumers understand the benefits and safety of these biotechnologies. Dietitians can play an important role in providing information to consumers about the safety and benefits of bST and pST.

Homeorhetic actions on tissue protein metabolism after the administration of rat growth hormone to normal rats

An acute treatment with rat growth hormone (1 microgram/g) to intact female rats produced immediate changes in muscle and bone protein synthesis as well as in muscle protein breakdown, while glucose and glutamate-piruvate transaminase plasma levels were not altered. These effects, apparently, are not mediated by systemic insulin-like growth factor I. Also a long-term treatment with somatotropin (0.1 microgram/g/d) for 22 days was performed, in which protein synthesis rates in muscle, liver and bone remained unchanged. However, the growth hormone long-term treatment induced a decrease in muscle proteolytic activity and an increase in tibia weight. In this context, this experiment describes, apparently for the first time, the systemic effect of growth hormone in entire female rats. Data suggest that a single dose of rat growth hormone produces immediate changes in tissue protein metabolism, through a direct effect of growth hormone. These effects were not observed after the long-term growth hormone treatment, although these animals showed an increased in tibia proportions.

Growth hormone binding proteins in pig adipose tissue: number, size and effects of pGH treatment on pGH and bGH binding

The present study was undertaken to determine the number and size of growth hormone binding proteins present in pig adipose tissue, determine if there were differences in binding of pGH and bGH to adipose tissue membranes and establish the effects of pGH treatment on GH binding. Administration of pGH (0, 25, 50 or 100 micrograms pGH/kg BW/d) for 7 d did not affect binding of [125I]bGH to adipose tissue microsomes. Maximum binding of bGH was approximately 8-fold higher than that observed for pGH. Half-maximal inhibition of [125I]bGH binding was observed at 11 ng/ml of bGH. In contrast, a more than 10-fold greater concentration of pGH was required to half-maximally inhibit [125I]pGH binding. bGH and pGH both bound to the same GH binding proteins (Mr of 92,000, 73,000 and 53,000). The GH binding proteins appear to be produced by post-translational modification of a single GH receptor transcript rather than alternative splicing of a primary transcript since only one GH receptor mRNA transcript (4.2 kb) was detected on Northern analysis. Our findings indicate that: 1) bGH is the preferred ligand to use to study GH binding in pig adipose tissue membranes (or adipocytes); 2) exogenous pGH does not alter GH binding; and 3) only one GH receptor mRNA transcript is present in pig adipose tissue.

An improved method for isolating RNA from porcine adipose tissue

In the present study, we describe a method that we developed to isolate total RNA from porcine adipose tissue. This method entails homogenizing porcine adipose tissue in 10 ml of 4 M guanidium thiocyanate, 25 mM sodium citrate, 0.5% Sarcosyl, 0.1 M beta-mercaptoethanol, pH 7.0, and then performing two CHCl3 extractions to remove lipid before following the procedure described by P. Chomczynski and N. Sacchi (1987, Anal. Biochem. 162, 156-159). This modification improved the yield of RNA approximately threefold (yield was 88 +/- 7 micrograms total RNA/g of tissue) without affecting RNA quality.